Scientific Opinion on the substantiation of health claims related to acacia gum (gum Arabic) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 758), changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract (ID 759), changes in bowel function (ID 759), reduction of gastro-intestinal discomfort (ID 759), maintenance of faecal nitrogen content and/or normal blood urea concentrations (ID 840, 1975), and maintenance of normal blood LDL cholesterol concentrations (ID 841) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Acacia gum (gum Arabic), potentially pathogenic microorganisms, bowel function, gastro-intestinal discomfort, SCFA production, pH, blood urea, faecal nitrogen, LDL-cholesterol, health claims
First published in the EFSA Journal
8 April 2011
12 November 2010
Scientific Opinion


No abstract available

Panel members at the time of adoption

Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
nda [at]
EFSA Journal 2011;9(4):2022
On request from
European Commission